- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 9.4369 ↓ -0.46%
[as on 13 February, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of Baroda BNP Paribas Health and Wellness Fund Direct Growth and its peers as on 13 February, 2026
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| Baroda BNP Paribas Health and Wellness Fund Direct Growth | -1.05% | -0.46% | 1.55% | -0.87% | -2.73% | - | - | - | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -3.44% | -1.05% | 0.6% | -1.55% | -4.72% | 1.29% | 13.92% | 16.69% | 16.2% | 16.86% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -1.92% | -0.96% | -0.17% | -0.93% | -1.11% | 10.24% | 14.69% | 12.18% | 14.56% | 14.93% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | -0.71% | -1.01% | 1.53% | -0.77% | -3.47% | 3.79% | 25.54% | 16.87% | 21.41% | 13.46% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -1.43% | -1.21% | -0.35% | 1.76% | -1.33% | 8.93% | 22.39% | 21.1% | 21.08% | 18.32% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 5.59% | -1.19% | 1.43% | 5.81% | 6.15% | 30.1% | 35.14% | 29.88% | 23.35% | 18.01% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | - | - | - | - | - |
Discrete returns (monthly)
| Month | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 |
|---|
| Returns | - | - | - | 1.04% | -1.62% | -2.5% | 1.71% | -0.38% | -1.32% | -4.12% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 95.53% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
4.47% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 9.25% |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 7.29% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 7.05% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.18% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 5.54% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.38% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 4.91% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 4.57% |
| AstraZeneca Pharma India Limited | ASTRAZEN (INE203A01020) | Pharmaceuticals & Biotechnology | 4.00% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 3.73% |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.73% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 3.06% |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 2.95% |
| Rainbow Childrens Medicare Limited | RAINBOW (INE961O01016) | Healthcare Services | 2.87% |
| ICICI Prudential Life Insurance Company Limited | ICICIPRULI (INE726G01019) | Insurance | 2.76% |
| JB Chemicals & Pharmaceuticals Limited | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 2.71% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.65% |
| Natco Pharma Limited | NATCOPHARM (INE987B01026) | Pharmaceuticals & Biotechnology | 2.64% |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 2.43% |
| Poly Medicure Limited | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 2.41% |
| Dr. Lal Path Labs Limited | LALPATHLAB (INE600L01024) | Healthcare Services | 2.02% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.93% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 1.90% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 1.65% |
| MedPlus Health Services Limited | MEDPLUS (INE804L01022) | Retailing | 1.41% |
| Jupiter Life Line Hospitals Limited | JLHL (INE682M01012) | Healthcare Services | 0.51% |
Portfolio data is as on date 31 October, 2025
NAV history
Baroda BNP Paribas Health and Wellness Fund Direct Growth - 30 days NAV (Net asset value) history
| Date | NAV |
|---|
| 13 February, 2026 | 9.4369 |
| 12 February, 2026 | 9.4808 |
| 11 February, 2026 | 9.5148 |
| 10 February, 2026 | 9.4270 |
| 9 February, 2026 | 9.3781 |
| 6 February, 2026 | 9.2927 |
| 5 February, 2026 | 9.2952 |
| 4 February, 2026 | 9.2956 |
| 3 February, 2026 | 9.3104 |
| 2 February, 2026 | 9.1443 |
| 30 January, 2026 | 9.1595 |
| 29 January, 2026 | 9.0594 |
| 28 January, 2026 | 9.1279 |
| 27 January, 2026 | 9.1471 |
| 23 January, 2026 | 9.1498 |
| 22 January, 2026 | 9.2631 |
| 21 January, 2026 | 9.1959 |
| 20 January, 2026 | 9.2033 |
| 19 January, 2026 | 9.3602 |
| 16 January, 2026 | 9.4415 |
| 14 January, 2026 | 9.5303 |
| 13 January, 2026 | 9.5195 |
| 12 January, 2026 | 9.5113 |
| 9 January, 2026 | 9.5625 |
| 8 January, 2026 | 9.6404 |
| 7 January, 2026 | 9.7378 |
| 6 January, 2026 | 9.6875 |
| 5 January, 2026 | 9.5715 |
| 2 January, 2026 | 9.5791 |
| 1 January, 2026 | 9.5375 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Baroda BNP Paribas Health and Wellness Fund Direct Growth?
The latest NAV of Baroda BNP Paribas Health and Wellness Fund Direct Growth is 9.4369 as on 13 February, 2026.
What are YTD (year to date) returns of Baroda BNP Paribas Health and Wellness Fund Direct Growth?
The YTD (year to date) returns of Baroda BNP Paribas Health and Wellness Fund Direct Growth are -1.05% as on 13 February, 2026.